Improve patient mood with compassion

Trial ID
NCT07097298
Official Title
Empathy and (Self-)Compassion to Improve the Quality of Life of Parkinson's Disease Patients and Caregivers: an Exploratory Study
Goal
Improve patient mood with compassion
Phase
NA
Status
RECRUITING
Sponsor
Alain Kaelin
Study Type
INTERVENTIONAL
Enrollment
30 participants
Conditions
Parkinson Disease(PD)
Interventions
empathy and compassion training

Plain-Language Summary

Aims to boost quality of life for people with Parkinson's and their caregivers by teaching empathy and self-compassion skills to reduce stress, improve emotional connection, and help with day-to-day coping. Participants and their regular caregivers take part in structured training that uses practical exercises like perspective-taking, kind self-talk, and emotion-regulation techniques, so it changes how people respond to stress and caregiving strain rather than using a drug. Looking for people aged 50 to 80 with Parkinson's at Hoehn and Yahr stage 3 or lower, able to consent with an MMSE score of 26 or higher and at least secondary education, who have a regular caregiver at home; caregivers must provide care at least 3 days per week for at least 3 months and also have at least secondary education. This is a small exploratory trial enrolling about 30 pairs, aimed at testing feasibility and early signals of benefit.

Locations

  • Istituto di Neuroscienze Cliniche della Svizzera Italiana, EOC, Lugano, Switzerland

Frequently Asked Questions

What is this trial testing?
This trial is studying empathy and compassion training. Aims to boost quality of life for people with Parkinson's and their caregivers by teaching empathy and self-compassion skills to reduce stress, improve emotional connection, and help with day-to-day coping. Participants and their regular caregivers take part in structured training that uses practical exercises like perspective-taking, kind self-talk, and emotion-regulation techniques, so it changes how people respond to stress and caregiving strain rather than using a drug. Looking for people aged 50 to 80 with Parkinson's at Hoehn and Yahr stage 3 or lower, able to consent with an MMSE score of 26 or higher and at least secondary education, who have a regular caregiver at home; caregivers must provide care at least 3 days per week for at least 3 months and also have at least secondary education. This is a small exploratory trial enrolling about 30 pairs, aimed at testing feasibility and early signals of benefit.
Who can participate?
Participants must be between 50 Years and 80 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 1 year and 8 months.

View on ClinicalTrials.gov